Exact Mass: 602.3315

(-)-Guttiferone E

C38H50O6 (602.3607)

Garcinol is a monoterpenoid. CID 5281560 is a natural product found in Garcinia assugu, Garcinia pedunculata, and other organisms with data available. (-)-Guttiferone E is found in fruits. (-)-Guttiferone E is a constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. Constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. (-)-Guttiferone E is found in fruits. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].

Xanthochymol

C38H50O6 (602.3607)

Xanthochymol is found in fruits. Xanthochymol is a constituent of the famine food Garcinia xanthochymus

Avermectin A2b aglycone

C34H50O9 (602.3455)

Avermectin B2a aglycone

C34H50O9 (602.3455)

Dolichyl D-mannosyl phosphate

C31H55O9P (602.3584)

dolichyl beta-D-glucosyl phosphate

C31H55O9P (602.3584)

A polyprenyl glycosyl phosphate having dolichyl as the polyprenyl component and beta-D-glucose as the glycosyl component.

Physapruin B

C34H50O9 (602.3455)

Physapruin B is found in fruits. Physapruin B is a constituent of Physalis pruinosa (strawberry tomato).

(+)-Isoxanthochymol

C38H50O6 (602.3607)

(-)-Isoxanthochymol is found in herbs and spices. (-)-Isoxanthochymol is found in the latex of Garcinia indica (kokam) and Garcinia cambogi

Guttiferone A

C38H50O6 (602.3607)

Guttiferone A is found in fruits. Guttiferone A is a constituent of Garcinia livingstonei (imbe). Constituent of Garcinia livingstonei (imbe). Guttiferone A is found in fruits.

Elsibucol

C35H54O4S2 (602.3463)

Garcinol

C38H50O6 (602.3607)

PA(10:0/18:2(10E,12Z)+=O(9))

C31H55O9P (602.3584)

PA(10:0/18:2(10E,12Z)+=O(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:2(10E,12Z)+=O(9)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(10E,12Z)+=O(9)/10:0)

C31H55O9P (602.3584)

PA(18:2(10E,12Z)+=O(9)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(10E,12Z)+=O(9)/10:0), in particular, consists of one chain of one 9-oxo-octadecadienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:2(9Z,11E)+=O(13))

C31H55O9P (602.3584)

PA(10:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:2(9Z,11E)+=O(13)/10:0)

C31H55O9P (602.3584)

PA(18:2(9Z,11E)+=O(13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:2(9Z,11E)+=O(13)/10:0), in particular, consists of one chain of one 13-oxo-octadecadienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:3(10,12,15)-OH(9))

C31H55O9P (602.3584)

PA(10:0/18:3(10,12,15)-OH(9)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:3(10,12,15)-OH(9)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(10,12,15)-OH(9)/10:0)

C31H55O9P (602.3584)

PA(18:3(10,12,15)-OH(9)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(10,12,15)-OH(9)/10:0), in particular, consists of one chain of one 9-hydroxyoctadecatrienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:3(9,11,15)-OH(13))

C31H55O9P (602.3584)

PA(10:0/18:3(9,11,15)-OH(13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:3(9,11,15)-OH(13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 13-hydroxyoctadecatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:3(9,11,15)-OH(13)/10:0)

C31H55O9P (602.3584)

PA(18:3(9,11,15)-OH(13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:3(9,11,15)-OH(13)/10:0), in particular, consists of one chain of one 13-hydroxyoctadecatrienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/20:3(6,8,11)-OH(5))

C31H55O9P (602.3584)

PA(8:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:3(6,8,11)-OH(5)/8:0)

C31H55O9P (602.3584)

PA(20:3(6,8,11)-OH(5)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(6,8,11)-OH(5)/8:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Coccinone G

C38H50O6 (602.3607)

guttiferone H

C38H50O6 (602.3607)

cycloxanthochymol

C38H50O6 (602.3607)

(-)-Demethylnorpleiomutine

C39H46N4O2 (602.3621)

Oblongifolin B

C38H50O6 (602.3607)

Guttiferone I

C38H50O6 (602.3607)

Dichapetalin I

C38H50O6 (602.3607)

Wikstroelide M

C34H50O9 (602.3455)

Coccinone F

C38H50O6 (602.3607)

Coccinone A

C38H50O6 (602.3607)

Coccinone H

C38H50O6 (602.3607)

Gambospiroene

C37H46O7 (602.3243)

6-Hydroxyzofimarin

C33H46O10 (602.3091)

camboginol

C38H50O6 (602.3607)

isoxanthochymol

C38H50O6 (602.3607)

A natural product found in Rheedia edulis and Garcinia livingstonei.

(-)-cycloxanthochymol

C38H50O6 (602.3607)

Desferrioxamine Et1

C26H46N6O10 (602.3275)

N-demethyltabernamine

C39H46N4O2 (602.3621)

18,18-bishydroxy matopensine

C38H42N4O3 (602.3257)

beauverolide Ja

C35H46N4O5 (602.3468)

(-)-Guttiferone E

C38H50O6 (602.3607)

(-)-Guttiferone E is found in fruits. (-)-Guttiferone E is a constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. Constituent of Garcinia indica (kokam). Camboginol isolated from Garcinia cambogia. (-)-Guttiferone E is found in fruits. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].

Diacetyltetrahydrocucurbitacin I

C34H50O9 (602.3455)

thyrsiferol

C31H55BrO6 (602.3182)

8-benzoyl-6,10-di-(3-methyl-2-butenyl)-3-[5-(1-hydroxy-1methylethyl)-2-methyltetrahydrofuran-2-yl]-4-oxatricyclo[6,3,1,0(1,5)]dodecane-7,12-dione|otogirinin E

C38H50O6 (602.3607)

Trapoxin A

C34H42N4O6 (602.3104)

A homodetic cyclic tetrapeptide constructed from L-phenylalanyl (x2), D-pipecolinyl and L-2-amino-8-oxo-9,10-epoxydecanoyl residues. D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

12-(2,4-Undecadienoyl),13-Ac-(4beta,7beta,9alphabeta,12beta,13alpha)-7-Hydroperoxy-4,9,12,13,20-pentahydroxy-1,5-tigliadien-3-one

C33H46O10 (602.3091)

(11aR*)-8-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3a,4,12,13-tetrahydro-3a,7,9-trihydroxy-3-(hydroxymethyl)-13,13-dimethyl-10-(3-methylbut-2-en-1-yl)-4,12-methanocyclopenta[c]furo[2,3-d]xanthen-6(1H)-one|gamboketanol

C37H46O7 (602.3243)

Isogarcinol

C38H50O6 (602.3607)

guangomide B|spicellamide A

C31H46N4O8 (602.3315)

(+)-xanthochymol

C38H50O6 (602.3607)

8,8-dimethyl-1-(3,4-dihydroxybenzoyl)-2-hydroxy-3,5-di(gamma,gamma-dimethylallyl)-7-(2-isopropenylhex-5-enyl)-7alphaH-trans-bicyclo[3.3.1]nona-2-en-4,9-dione|garcinielliptone FC

C38H50O6 (602.3607)

3-O-demethylspinosyn alpha

C34H50O9 (602.3455)

Anthranoyllycoctonine

C32H46N2O9 (602.3203)

garcinialiptone D

C38H50O6 (602.3607)

Me ester-Viridominic acid A

C34H50O9 (602.3455)

Xanthochymol

C38H50O6 (602.3607)

aphanalide B

C33H46O10 (602.3091)

hypercohin I

C38H50O6 (602.3607)

C34H50O9

C34H50O9 (602.3455)

6-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside

C30H50O12 (602.3302)

dictamin B

C33H46O10 (602.3091)

thorelione A

C38H50O6 (602.3607)

Asterriquinone A4

C39H42N2O4 (602.3144)

Diacetyltangulinsaeure

C34H50O9 (602.3455)

C33H46O10

C33H46O10 (602.3091)

Ostodin

C33H46O10 (602.3091)

MS000182022

C39H42N2O4 (602.3144)

11alpha,15alpha-diacetoxybrachycarpon-22(23)-ene|15alpha-acetoxycleomblynol A

C33H46O10 (602.3091)

Corosin acetate

C34H50O9 (602.3455)

guttiferone F

C38H50O6 (602.3607)

A member of the class of benzophenones isolated from the stem bark of Allanblackia stuhlmannii and has been shown to exhibit antileishmanial and anticholinesterase activity.

MS000204792

C39H42N2O4 (602.3144)

(1RS,5RS,7RS,8SR)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione|guttiferone A

C38H50O6 (602.3607)

2-O-demethylspinosyn alpha

C34H50O9 (602.3455)

Asterriquinone A2

C39H42N2O4 (602.3144)

Lys His Tyr Arg

C27H42N10O6 (602.3289)

Lys Asn Gly Glu Arg

C23H42N10O9 (602.3136)

Arg Val Ser Leu Asp

C25H46N8O9 (602.3388)

Arg Pro Pro Ser Phe

C28H42N8O7 (602.3176)

His Gln Tyr Arg

C26H38N10O7 (602.2925)

Lys Val Glu Ile Asp

C26H46N6O10 (602.3275)

Ile Ser Asp Arg Ile

C25H46N8O9 (602.3388)

Pro Pro Lys Phe Asp

C29H42N6O8 (602.3064)

His Tyr Arg Lys

C27H42N10O6 (602.3289)

Lys Asp Leu Ser Leu

C27H50N6O9 (602.3639)

Gly Leu Asp Val Trp

C29H42N6O8 (602.3064)

Arg Glu Ala Asp Ile

C24H42N8O10 (602.3024)

Glu Lys Leu Glu Ala

C26H46N6O10 (602.3275)

cambogin

C38H50O6 (602.3607)

Garcinol is a monoterpenoid. CID 5281560 is a natural product found in Garcinia assugu, Garcinia pedunculata, and other organisms with data available. Isogarcinol is a natural product found in Garcinia pedunculata, Garcinia cowa, and other organisms with data available. Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].

7-epi-Isogarcinol

C38H50O6 (602.3607)

7-Epi-Isogarcinol is a natural product found in Symphonia globulifera, Garcinia griffithii, and other organisms with data available.

MLS001076487-01!Ouabain octahydrate

C29H46O13 (602.2938)

desferrioxamine D1

C27H50N6O9 (602.3639)

4,15,26-trihydroxy-1-oxa-4,9,15,20,26,31-hexazacyclotritriacontane-5,8,16,19,27,30-hexone

C26H46N6O10 (602.3275)

4,15,26-trihydroxy-1-oxa-4,9,15,20,26,31-hexazacyclotritriacontane-5,8,16,19,27,30-hexone_major

C26H46N6O10 (602.3275)

Glu Ile Arg Trp

C28H42N8O7 (602.3176)

Glu Ile Trp Arg

C28H42N8O7 (602.3176)

Glu Leu Arg Trp

C28H42N8O7 (602.3176)

Glu Leu Trp Arg

C28H42N8O7 (602.3176)

Glu Arg Ile Trp

C28H42N8O7 (602.3176)

Glu Arg Leu Trp

C28H42N8O7 (602.3176)

Glu Arg Trp Ile

C28H42N8O7 (602.3176)

Glu Arg Trp Leu

C28H42N8O7 (602.3176)

Glu Trp Ile Arg

C28H42N8O7 (602.3176)

Glu Trp Leu Arg

C28H42N8O7 (602.3176)

Glu Trp Arg Ile

C28H42N8O7 (602.3176)

Glu Trp Arg Leu

C28H42N8O7 (602.3176)

His Lys Arg Tyr

C27H42N10O6 (602.3289)

His Lys Tyr Arg

C27H42N10O6 (602.3289)

His Gln Arg Tyr

C26H38N10O7 (602.2925)

His Arg Lys Tyr

C27H42N10O6 (602.3289)

His Arg Gln Tyr

C26H38N10O7 (602.2925)

His Arg Tyr Lys

C27H42N10O6 (602.3289)

His Arg Tyr Gln

C26H38N10O7 (602.2925)

His Tyr Lys Arg

C27H42N10O6 (602.3289)

His Tyr Gln Arg

C26H38N10O7 (602.2925)

His Tyr Arg Gln

C26H38N10O7 (602.2925)

Ile Glu Arg Trp

C28H42N8O7 (602.3176)

Ile Glu Trp Arg

C28H42N8O7 (602.3176)

Ile Arg Glu Trp

C28H42N8O7 (602.3176)

Ile Arg Trp Glu

C28H42N8O7 (602.3176)

Ile Val Trp Trp

C33H42N6O5 (602.3217)

Ile Trp Glu Arg

C28H42N8O7 (602.3176)

Ile Trp Arg Glu

C28H42N8O7 (602.3176)

Ile Trp Val Trp

C33H42N6O5 (602.3217)

Ile Trp Trp Val

C33H42N6O5 (602.3217)

Lys His Arg Tyr

C27H42N10O6 (602.3289)

Lys Asn Arg Trp

C27H42N10O6 (602.3289)

Lys Asn Trp Arg

C27H42N10O6 (602.3289)

Lys Arg His Tyr

C27H42N10O6 (602.3289)

Lys Arg Asn Trp

C27H42N10O6 (602.3289)

Lys Arg Trp Asn

C27H42N10O6 (602.3289)

Lys Arg Tyr His

C27H42N10O6 (602.3289)

Lys Trp Asn Arg

C27H42N10O6 (602.3289)

Lys Trp Arg Asn

C27H42N10O6 (602.3289)

Lys Tyr His Arg

C27H42N10O6 (602.3289)

Lys Tyr Arg His

C27H42N10O6 (602.3289)

Leu Glu Arg Trp

C28H42N8O7 (602.3176)

Leu Glu Trp Arg

C28H42N8O7 (602.3176)

Leu Arg Glu Trp

C28H42N8O7 (602.3176)

Leu Arg Trp Glu

C28H42N8O7 (602.3176)

Leu Val Trp Trp

C33H42N6O5 (602.3217)

Leu Trp Glu Arg

C28H42N8O7 (602.3176)

Leu Trp Arg Glu

C28H42N8O7 (602.3176)

Leu Trp Val Trp

C33H42N6O5 (602.3217)

Leu Trp Trp Val

C33H42N6O5 (602.3217)

Asn Lys Arg Trp

C27H42N10O6 (602.3289)

Asn Lys Trp Arg

C27H42N10O6 (602.3289)

Asn Gln Arg Trp

C26H38N10O7 (602.2925)

Asn Gln Trp Arg

C26H38N10O7 (602.2925)

Asn Arg Lys Trp

C27H42N10O6 (602.3289)

Asn Arg Gln Trp

C26H38N10O7 (602.2925)

Asn Arg Trp Lys

C27H42N10O6 (602.3289)

Asn Arg Trp Gln

C26H38N10O7 (602.2925)

Asn Trp Lys Arg

C27H42N10O6 (602.3289)

Asn Trp Arg Lys

C27H42N10O6 (602.3289)

Arg Glu Ile Trp

C28H42N8O7 (602.3176)

Arg Glu Leu Trp

C28H42N8O7 (602.3176)

Arg Glu Trp Ile

C28H42N8O7 (602.3176)

Arg Glu Trp Leu

C28H42N8O7 (602.3176)

Arg His Lys Tyr

C27H42N10O6 (602.3289)

Arg His Tyr Lys

C27H42N10O6 (602.3289)

Arg Ile Glu Trp

C28H42N8O7 (602.3176)

Arg Ile Trp Glu

C28H42N8O7 (602.3176)

Arg Lys His Tyr

C27H42N10O6 (602.3289)

Arg Lys Asn Trp

C27H42N10O6 (602.3289)

Arg Lys Trp Asn

C27H42N10O6 (602.3289)

Arg Lys Tyr His

C27H42N10O6 (602.3289)

Arg Leu Glu Trp

C28H42N8O7 (602.3176)

Arg Leu Trp Glu

C28H42N8O7 (602.3176)

Arg Asn Lys Trp

C27H42N10O6 (602.3289)

Arg Asn Trp Lys

C27H42N10O6 (602.3289)

Arg Trp Glu Ile

C28H42N8O7 (602.3176)

Arg Trp Glu Leu

C28H42N8O7 (602.3176)

Arg Trp Ile Glu

C28H42N8O7 (602.3176)

Arg Trp Lys Asn

C27H42N10O6 (602.3289)

Arg Trp Leu Glu

C28H42N8O7 (602.3176)

Arg Trp Asn Lys

C27H42N10O6 (602.3289)

Arg Tyr His Lys

C27H42N10O6 (602.3289)

Arg Tyr Lys His

C27H42N10O6 (602.3289)

Val Ile Trp Trp

C33H42N6O5 (602.3217)

Val Leu Trp Trp

C33H42N6O5 (602.3217)

Val Trp Ile Trp

C33H42N6O5 (602.3217)

Val Trp Leu Trp

C33H42N6O5 (602.3217)

Val Trp Trp Ile

C33H42N6O5 (602.3217)

Val Trp Trp Leu

C33H42N6O5 (602.3217)

Trp Glu Ile Arg

C28H42N8O7 (602.3176)

Trp Glu Leu Arg

C28H42N8O7 (602.3176)

Trp Glu Arg Ile

C28H42N8O7 (602.3176)

Trp Glu Arg Leu

C28H42N8O7 (602.3176)

Trp Ile Glu Arg

C28H42N8O7 (602.3176)

Trp Ile Arg Glu

C28H42N8O7 (602.3176)

Trp Ile Val Trp

C33H42N6O5 (602.3217)

Trp Ile Trp Val

C33H42N6O5 (602.3217)

Trp Lys Asn Arg

C27H42N10O6 (602.3289)

Trp Lys Arg Asn

C27H42N10O6 (602.3289)

Trp Leu Glu Arg

C28H42N8O7 (602.3176)

Trp Leu Arg Glu

C28H42N8O7 (602.3176)

Trp Leu Val Trp

C33H42N6O5 (602.3217)

Trp Leu Trp Val

C33H42N6O5 (602.3217)

Trp Asn Lys Arg

C27H42N10O6 (602.3289)

Trp Asn Arg Lys

C27H42N10O6 (602.3289)

Trp Arg Glu Ile

C28H42N8O7 (602.3176)

Trp Arg Glu Leu

C28H42N8O7 (602.3176)

Trp Arg Ile Glu

C28H42N8O7 (602.3176)

Trp Arg Lys Asn

C27H42N10O6 (602.3289)

Trp Arg Leu Glu

C28H42N8O7 (602.3176)

Trp Arg Asn Lys

C27H42N10O6 (602.3289)

Trp Val Ile Trp

C33H42N6O5 (602.3217)

Trp Val Leu Trp

C33H42N6O5 (602.3217)

Trp Val Trp Ile

C33H42N6O5 (602.3217)

Trp Val Trp Leu

C33H42N6O5 (602.3217)

Trp Trp Ile Val

C33H42N6O5 (602.3217)

Trp Trp Leu Val

C33H42N6O5 (602.3217)

Trp Trp Val Ile

C33H42N6O5 (602.3217)

Trp Trp Val Leu

C33H42N6O5 (602.3217)

Tyr His Lys Arg

C27H42N10O6 (602.3289)

Tyr His Arg Lys

C27H42N10O6 (602.3289)

Tyr Lys His Arg

C27H42N10O6 (602.3289)

Tyr Lys Arg His

C27H42N10O6 (602.3289)

Tyr Arg His Lys

C27H42N10O6 (602.3289)

Tyr Arg Lys His

C27H42N10O6 (602.3289)

KNGER

C23H42N10O9 (602.3136)

KVEID

C26H46N6O10 (602.3275)

ISDRI

C25H46N8O9 (602.3388)

RPPSF

C28H42N8O7 (602.3176)

READI

C24H42N8O10 (602.3024)

PPKFD

C29H42N6O8 (602.3064)

SLRLD

C25H46N8O9 (602.3388)

guttiferone A

C38H50O6 (602.3607)

Physapruin B

C34H50O9 (602.3455)

Wikstrocin C

C34H50O9 (602.3455)

6-O-Linolenylsucrose

C30H50O12 (602.3302)

YTTRIUM(III) NEODECANOATE

C30H57O6Y (602.3213)

ELSIBUCOL

C35H54O4S2 (602.3463)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C26170 - Protective Agent > C275 - Antioxidant

Withalongolide K

C33H46O10 (602.3091)

A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.

(3E)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-(5-methyl-2-prop-1-en-2-ylhex-5-enyl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(-)-Guttiferone E

C38H50O6 (602.3607)

(+)-Guttiferone a

C38H50O6 (602.3607)

(3Z)-3-[(3,4-dihydroxyphenyl)-hydroxymethylidene]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-(5-methyl-2-prop-1-en-2-ylhex-4-enyl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

PA(10:0/18:2(10E,12Z)+=O(9))

C31H55O9P (602.3584)

PA(18:2(10E,12Z)+=O(9)/10:0)

C31H55O9P (602.3584)

PA(10:0/18:2(9Z,11E)+=O(13))

C31H55O9P (602.3584)

PA(18:2(9Z,11E)+=O(13)/10:0)

C31H55O9P (602.3584)

[(2R)-1-octanoyloxy-3-phosphonooxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H55O9P (602.3584)

[(2R)-2-octanoyloxy-3-phosphonooxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate

C31H55O9P (602.3584)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H55O9P (602.3584)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C31H55O9P (602.3584)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H55O9P (602.3584)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C31H55O9P (602.3584)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(Z)-7-[3-[(2Z,5Z)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5R,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-3-acetyloxy-2-[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

2-[[(2R)-2-acetyloxy-3-[(5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO9P+ (602.3458)

Garcinol

C38H50O6 (602.3607)

Garcinol, a polyisoprenylated benzophenone harvested from Garcinia indica, exerts anti-cholinesterase properties towards acetyl cholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50s of 0.66 μM and 7.39 μM, respectively[1]. Garcinol also inhibits histone acetyltransferases (HATs, IC50= 7 μM) and p300/CPB-associated factor (PCAF, IC50 = 5 μM). Garcinol has anti-inflammatory and anti-cancer activity[2].

3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one;hydrate

C29H46O13 (602.2938)

guttiferone E

C38H50O6 (602.3607)

A natural product found in Rheedia edulis and Garcinia livingstonei.

CID 21125413

C38H50O6 (602.3607)

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate

C31H55O9P (602.3584)

Guttiferonea

C38H50O6 (602.3607)

4-(dimethylamino)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

3-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[oxo(1-piperidinyl)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide

C34H42N4O4S (602.2927)

(3S)-2-[(S)-tert-butylsulfinyl]-N-cyclopentyl-4-[3-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H42N4O4S (602.2927)

3-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[oxo(1-piperidinyl)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide

C34H42N4O4S (602.2927)

4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C35H46N4O5 (602.3468)

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide

C35H46N4O5 (602.3468)

(3R)-2-[(R)-tert-butylsulfinyl]-N-cyclopentyl-4-[3-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide

C34H42N4O4S (602.2927)

(1S,5R,7S)-3-[(3,4-dihydroxyphenyl)-oxomethyl]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)-1-[(2S)-5-methyl-2-(1-methylethenyl)hex-4-enyl]bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C30H51O10P (602.322)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C30H51O10P (602.322)

[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C30H51O10P (602.322)

[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C30H51O10P (602.322)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C30H51O10P (602.322)

[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C30H51O10P (602.322)

[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C30H51O10P (602.322)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C30H51O10P (602.322)

(+)-Isoxanthochymol

C38H50O6 (602.3607)

Guttiferone A (rel-(+))

C38H50O6 (602.3607)

A natural product found in Symphonia globulifera and Garcinia livingstonei.

guttiferone A, (rel-(+))-

C38H50O6 (602.3607)

A natural product found in Garcinia livingstonei and Rheedia edulis.

Dolichyl beta-D-mannosyl phosphate

C31H55O9P (602.3584)

DGGA 21:2;O

C30H50O12 (602.3302)

DGGA 22:1

C31H54O11 (602.3666)

PA O-27:5;O3

C30H51O10P (602.322)

PA O-28:4;O2

C31H55O9P (602.3584)

PA P-16:0/12:3;O2

C31H55O9P (602.3584)

PA P-16:1/11:3;O3

C30H51O10P (602.322)

PA P-16:1/12:2;O2

C31H55O9P (602.3584)

PA P-20:0/8:3;O2

C31H55O9P (602.3584)

PA P-20:1/7:3;O3

C30H51O10P (602.322)

PA P-20:1/8:2;O2

C31H55O9P (602.3584)

PA 14:0/13:4;O2

C30H51O10P (602.322)

PA 14:1/13:3;O2

C30H51O10P (602.322)

PA 16:0/12:3;O

C31H55O9P (602.3584)

PA 18:0/9:4;O2

C30H51O10P (602.322)

PA 18:3/9:1;O2

C30H51O10P (602.322)

PA 20:0/8:3;O

C31H55O9P (602.3584)

PA 20:1/7:3;O2

C30H51O10P (602.322)

PA 20:2/7:2;O2

C30H51O10P (602.322)

PA 20:2/8:1;O

C31H55O9P (602.3584)

PA 22:1/6:2;O

C31H55O9P (602.3584)

PA 27:4;O2

C30H51O10P (602.322)

PA 28:3;O

C31H55O9P (602.3584)

LPGP P-20:1

C26H52O11P2 (602.2985)

PG O-24:5;O

C30H51O10P (602.322)

PG P-16:1/8:3;O

C30H51O10P (602.322)

PG P-18:1/6:3;O

C30H51O10P (602.322)

PG 2:0_22:4

C30H51O10P (602.322)

PG 20:3/4:1

C30H51O10P (602.322)

PG 20:4/4:0

C30H51O10P (602.322)

PG 22:4/2:0

C30H51O10P (602.322)

PG 24:4

C30H51O10P (602.322)

PEth 26:3;O

C31H55O9P (602.3584)

PM 27:3;O

C31H55O9P (602.3584)

ST 23:1;O7;GlcA

C29H46O13 (602.2938)

ST 24:0;O6;GlcA

C30H50O12 (602.3302)

ST 27:5;O4;GlcA

C33H46O10 (602.3091)

ST 28:4;O3;GlcA

C34H50O9 (602.3455)

ST 23:2;O8;Hex

C29H46O13 (602.2938)

ST 24:1;O7;Hex

C30H50O12 (602.3302)

ST 25:0;O6;Hex

C31H54O11 (602.3666)

ST 27:6;O5;Hex

C33H46O10 (602.3091)

ST 28:5;O4;Hex

C34H50O9 (602.3455)

(1s,5s,6s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,2s,5r,9s,10r,12r)-5-[(r)-furan-3-yl(methoxy)methyl]-12-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-6-(2-methoxy-2-oxoethyl)-1,5,11,11-tetramethyl-13-oxotricyclo[7.3.1.0²,⁷]tridec-6-en-10-yl 2-methylpropanoate

C33H46O10 (602.3091)

(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(3s,5r)-3-[(1r,2r,3r,5r,6r,9s,14r,15r,17r,18s,19s)-3,17-dihydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]oxolan-2-one

C38H50O6 (602.3607)

[(1r,2s,3s,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-2,8,9-trihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O9 (602.3203)

(1s,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

9-(but-1-en-1-yl)-13-hydroxy-2-[(3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl)oxy]-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C34H50O9 (602.3455)

(1s,3s,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,9r,16r,18r,21s)-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid

C39H46N4O2 (602.3621)

8-(3,4-dihydroxybenzoyl)-2,2-dimethyl-4a-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,6-bis(3-methylbut-2-en-1-yl)-4,6-dihydro-3h-1-benzopyran-5,7-dione

C38H50O6 (602.3607)

(1s,3z,5r,6s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,3s,8s,13s,15s)-11-(3,4-dihydroxybenzoyl)-6,6,8,14,14-pentamethyl-13,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione

C38H50O6 (602.3607)

(1s,3s,8r,10r)-8-benzoyl-3-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C38H50O6 (602.3607)

6-benzyl-13-(hexan-2-yl)-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-3-(sec-butyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C35H46N4O5 (602.3468)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)-5-[(2,4,4-trimethylcyclohex-2-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-5-[(3r)-2,7-dimethylocta-1,6-dien-3-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

4,8,15,19,26,30-hexahydroxy-1-oxa-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione

C26H46N6O10 (602.3275)

3-[(1r,1'r,2s,3ar,3'ar,5r,7'r,7as,7'ar)-1'-[(2r)-1-[(2s)-3,4-dimethyl-5-oxo-2h-furan-2-yl]propan-2-yl]-2,7'-dihydroxy-3'a,4,4,7a,7'a-pentamethyl-4'-oxo-decahydro-1'h-1,5'-spirobi[inden]-5-yloxy]-3-oxopropanoic acid

C34H50O9 (602.3455)

(1s,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-5,7-bis(3-methylbut-3-en-1-yl)-1-[(2,4,4-trimethylcyclohex-2-en-1-yl)methyl]bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

3-(3,4-dihydroxybenzoyl)-7-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

3,18-bis(acetyloxy)-2,7,7,11,12-pentamethyl-15-(2-methyl-5-oxofuran-2-yl)-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan-13-yl acetate

C33H46O10 (602.3091)

(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

5-[furan-3-yl(methoxy)methyl]-12-(1-hydroxy-2-methoxy-2-oxoethyl)-6-(2-methoxy-2-oxoethyl)-1,5,11,11-tetramethyl-13-oxotricyclo[7.3.1.0²,⁷]tridec-6-en-10-yl 2-methylpropanoate

C33H46O10 (602.3091)

(1s,2s,13s,14r,18s)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8,14-trihydroxy-15-(hydroxymethyl)-20,20-dimethyl-5-(3-methylbut-2-en-1-yl)-3,19-dioxahexacyclo[11.7.1.0²,¹¹.0²,¹⁸.0⁴,⁹.0¹⁴,¹⁸]henicosa-4,6,8,11,15-pentaen-10-one

C37H46O7 (602.3243)

5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl tetradeca-2,4-dienoate

C34H50O9 (602.3455)

3-(3,4-dihydroxybenzoyl)-5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

methyl (1s,14r,15e,18s)-12-[(1r,15r,17s,18s)-17-ethyl-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C39H46N4O2 (602.3621)

1-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-7-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-3,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,5s,7r,8s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,5s,7r)-3-(3,4-dihydroxybenzoyl)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1,7-bis(3-methylbut-3-en-1-yl)-5-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,3s,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1s,2r,3r,8r,11r,12r,13s,15s,16r,18r)-3,18-bis(acetyloxy)-2,7,7,11,12-pentamethyl-15-[(2s)-2-methyl-5-oxofuran-2-yl]-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadecan-13-yl acetate

C33H46O10 (602.3091)

(3s,5r)-3-[(1r,2r,3r,5r,6r,9s,14s,15r,17r,18s,19s)-3,17-dihydroxy-2,6,14-trimethyl-9-phenyl-8-oxahexacyclo[16.3.1.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]docos-11-en-19-yl]-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]oxolan-2-one

C38H50O6 (602.3607)

2-[(1r,9r,10s,11r,13s,17r,25s,26s,27s,28e,33s,36s,38e,39s)-38-(2-hydroxyethylidene)-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]ethanol

C38H42N4O3 (602.3257)

7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8,14-trihydroxy-15-(hydroxymethyl)-20,20-dimethyl-5-(3-methylbut-2-en-1-yl)-3,19-dioxahexacyclo[11.7.1.0²,¹¹.0²,¹⁸.0⁴,⁹.0¹⁴,¹⁸]henicosa-4,6,8,11,15-pentaen-10-one

C37H46O7 (602.3243)

(1r,5s,7s)-5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-1-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

[(1s,2r,3s)-1,2-dihydroxy-3-methoxy-2-[(2s,3s)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl]methyl (2r)-2-hydroxy-3-[(1s,5s,7r)-7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate

C34H50O9 (602.3455)

3-[hydroxy({5-[(1-hydroxyethylidene)amino]pentyl})carbamoyl]-n-[5-(n-hydroxy-3-{[5-(n-hydroxyacetamido)pentyl]-c-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid

C27H50N6O9 (602.3639)

9-(but-1-en-1-yl)-13-hydroxy-2-[(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)oxy]-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C34H50O9 (602.3455)

12-(3,4-dihydroxybenzoyl)-13-hydroxy-3,3,9,9-tetramethyl-8,10-bis(3-methylbut-2-en-1-yl)-4-(prop-1-en-2-yl)tricyclo[8.3.1.0¹,⁷]tetradec-12-ene-11,14-dione

C38H50O6 (602.3607)

(1r,3e,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,3r,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

methyl 2-[(1z,2s,3as,3bs,4r,5r,6s,7r,9as)-2,5-bis(acetyloxy)-4,7-dihydroxy-3a,3b,6,9a-tetramethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoate

C34H50O9 (602.3455)

2,5-dimethoxy-3-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-6-[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-2,5-diene-1,4-dione

C39H42N2O4 (602.3144)

(1r,3r,9s,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid

C39H46N4O2 (602.3621)

3-{1'-[1-(3,4-dimethyl-5-oxo-2h-furan-2-yl)propan-2-yl]-2,7'-dihydroxy-3'a,4,4,7a,7'a-pentamethyl-4'-oxo-decahydro-1'h-1,5'-spirobi[inden]-5-yloxy}-3-oxopropanoic acid

C34H50O9 (602.3455)

(1s,5r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,3z,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,3ar,6ar,12ar)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione

C37H46O7 (602.3243)

[(1s,2r,3s)-1,2-dihydroxy-3-methoxy-2-[(2s,3s)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl]methyl (2r)-2-hydroxy-3-[(1s,5s,7s)-7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate

C34H50O9 (602.3455)

8-benzoyl-3-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C38H50O6 (602.3607)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)-5-{[(1r)-2,4,4-trimethylcyclohex-2-en-1-yl]methyl}bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,4s,7s,8s,10s)-12-(3,4-dihydroxybenzoyl)-13-hydroxy-3,3,9,9-tetramethyl-8,10-bis(3-methylbut-2-en-1-yl)-4-(prop-1-en-2-yl)tricyclo[8.3.1.0¹,⁷]tetradec-12-ene-11,14-dione

C38H50O6 (602.3607)

15-benzyl-5,14-dihydroxy-6-isopropyl-3,9,10,12,16-pentamethyl-18-(2-methylpropyl)-1,7-dioxa-4,10,13,16-tetraazacyclooctadeca-4,13-diene-2,8,11,17-tetrone

C31H46N4O8 (602.3315)

3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,3e,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,5r,7r)-5-(3,4-dihydroxybenzoyl)-1-[(3r)-2,7-dimethylocta-1,6-dien-3-yl]-4-hydroxy-6,6-dimethyl-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(3r,6s,9s,13r)-6-benzyl-3-[(2r)-butan-2-yl]-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C35H46N4O5 (602.3468)

(1r,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(3r,6s,9s,13s)-6-benzyl-13-[(2s)-hexan-2-yl]-5,8,11-trihydroxy-9-(1h-indol-3-ylmethyl)-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C35H46N4O5 (602.3468)

(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-9-[(1e)-but-1-en-1-yl]-13-hydroxy-2-{[(2r,3r,4r,5r,6s)-4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl]oxy}-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C34H50O9 (602.3455)

(1r,5r,7s)-1-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-7-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-3,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,3r,9s,11s)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

2-({[(3as,7as)-6-hydroxy-1-[(2s)-2-[(1-hydroxyhexylidene)amino]-3-(4-hydroxyphenyl)propanoyl]-octahydroindol-2-yl](hydroxy)methylidene}amino)-5-carbamimidamidopentanoic acid

C30H46N6O7 (602.3428)

(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)-1-[(2,4,4-trimethylcyclohex-1-en-1-yl)methyl]bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,3s,9r,11s)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1r,3e,5s,6r,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(2r,3as,5ar,5bs,9r,13s,14r,16as,16br)-9-[(1e)-but-1-en-1-yl]-13-hydroxy-2-{[(2r,3r,4s,5s,6s)-3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl]oxy}-14-methyl-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C34H50O9 (602.3455)

(9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1s,3e,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-7-[5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,3-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

2-[({3-hydroxy-5-methoxy-6-methyl-4-[(2-methylhexa-2,4-dienoyl)oxy]oxan-2-yl}oxy)methyl]-9-(hydroxymethyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C34H50O9 (602.3455)

(1s,3z,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,3s,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1s,5s,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

{1,2-dihydroxy-3-methoxy-2-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-oxocyclohexyl}methyl 2-hydroxy-3-[7-methyl-2-methylidene-7-(4-methylpenta-1,3-dien-1-yl)-6-oxabicyclo[3.2.1]octan-5-yl]propanoate

C34H50O9 (602.3455)

9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione

C37H46O7 (602.3243)

{11-ethyl-2,8,9-trihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

C32H46N2O9 (602.3203)

(1r,5r,7s)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

11-(3,4-dihydroxybenzoyl)-3,6,6,14,14-pentamethyl-13,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione

C38H50O6 (602.3607)

(1s,3ar,6as,12ar)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione

C37H46O7 (602.3243)

(3s,6s,9s,15ar)-6,9-dibenzyl-1,4,7-trihydroxy-3-{6-[(2s)-oxiran-2-yl]-6-oxohexyl}-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C34H42N4O6 (602.3104)

3-(3,4-dihydroxybenzoyl)-4-hydroxy-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,2s,4r,5r,8r,9s,11s)-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-5-methoxy-6-methyl-4-{[(2z,4e)-2-methylhexa-2,4-dienoyl]oxy}oxan-2-yl]oxy}methyl)-9-(hydroxymethyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C34H50O9 (602.3455)

(1r,3e,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl (2z,4e)-tetradeca-2,4-dienoate

C34H50O9 (602.3455)

(1s,5s,7r)-3-(3,4-dihydroxybenzoyl)-5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

9-(3,7-dimethylocta-2,6-dien-1-yl)-8,10-dihydroxy-3,3,5'-trimethyl-11-(3-methylbut-2-en-1-yl)-4,6a-dihydro-3'h,3ah-spiro[furo[3,4-e]xanthene-1,2'-pyran]-6',7-dione

C37H46O7 (602.3243)

(1s,5s,7s)-5-(3,4-dihydroxybenzoyl)-4-hydroxy-6,6-dimethyl-7-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,3-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(3s,4ar,6s)-8-(3,4-dihydroxybenzoyl)-2,2-dimethyl-4a-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-3,6-bis(3-methylbut-2-en-1-yl)-4,6-dihydro-3h-1-benzopyran-5,7-dione

C38H50O6 (602.3607)

(1s,9r,16s,18r,21s)-6-[(15s,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7-triene-18-carboxylic acid

C39H46N4O2 (602.3621)

5-(3,4-dihydroxybenzoyl)-1-(2,7-dimethylocta-1,6-dien-3-yl)-4-hydroxy-6,6-dimethyl-3,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,5s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

2-[(38e)-38-(2-hydroxyethylidene)-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]ethanol

C38H42N4O3 (602.3257)

2,5-dimethoxy-3-[7-(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]-6-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]cyclohexa-2,5-diene-1,4-dione

C39H42N2O4 (602.3144)

(3s,6s,9s,12r,15r,18s)-15-benzyl-5,14-dihydroxy-6-isopropyl-3,9,10,12,16-pentamethyl-18-(2-methylpropyl)-1,7-dioxa-4,10,13,16-tetraazacyclooctadeca-4,13-diene-2,8,11,17-tetrone

C31H46N4O8 (602.3315)

(2r,3as,7as)-n-(5-carbamimidamido-1-oxopentan-2-yl)-1-[(2r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid

C30H46N6O7 (602.3428)

(1r,5s,6s,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6-methyl-1,5,7-tris(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

3-(3,4-dihydroxybenzoyl)-5-(2,7-dimethylocta-1,6-dien-3-yl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1s,3r,9r,11r)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-3,9,11-tris(3-methylbut-2-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1r,5r,7r)-3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-5-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-1,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-3-ene-2,9-dione

C38H50O6 (602.3607)

(1r,3z,5s,7s)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-5-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1s,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-tetradeca-2,4-dienoate

C34H50O9 (602.3455)

(1r,2s,4r,5s,6s,10s,11r,12r,14r,15r)-5,6,11,15-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-14-yl (4e)-tetradeca-2,4-dienoate

C34H50O9 (602.3455)

6,9-dibenzyl-1,4,7-trihydroxy-3-[6-(oxiran-2-yl)-6-oxohexyl]-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C34H42N4O6 (602.3104)

(1s,3e,5r,7r)-3-[(3,4-dihydroxyphenyl)(hydroxy)methylidene]-6,6-dimethyl-1-[(2r)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C38H50O6 (602.3607)

(1r,3s,9r,11s)-7-(3,4-dihydroxybenzoyl)-4,4,10,10-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-(3-methylbut-3-en-1-yl)-5-oxatricyclo[7.3.1.0¹,⁶]tridec-6-ene-8,13-dione

C38H50O6 (602.3607)

(1s,3s,8s,13s,15s)-11-(3,4-dihydroxybenzoyl)-3,6,6,14,14-pentamethyl-13,15-bis(3-methylbut-2-en-1-yl)-9-oxatetracyclo[11.3.1.0¹,¹⁰.0³,⁸]heptadec-10-ene-12,17-dione

C38H50O6 (602.3607)

(1s,4r,7r,8r,10s)-12-(3,4-dihydroxybenzoyl)-13-hydroxy-3,3,9,9-tetramethyl-8,10-bis(3-methylbut-2-en-1-yl)-4-(prop-1-en-2-yl)tricyclo[8.3.1.0¹,⁷]tetradec-12-ene-11,14-dione

C38H50O6 (602.3607)

(3as,7as)-n-(1-carbamimidoyl-2-hydroxypiperidin-3-yl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C30H46N6O7 (602.3428)